Neutral
IFP Advisors Inc grew its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 19,910.3% during the 4th quarter, acc...
Neutral
Swiss Life Asset Management Ltd significantly reduced its stake in Teva Pharmaceutical Industries (NYSE:TEVA) by 28.7% in the fourth quarter, selling ...
Neutral
Teva Pharmaceutical Industries Ltd. announced that Eric Hughes, EVP of Global R&D & Chief Medical Officer, will present at the BofA Securities Health ...